000			02077 a2200625 4500
005			20250517072356.0
264		0	_c20161213
008			201612s 0 0 eng d
022			_a1533-4023
024	7		_a10.1097/FJC.0000000000000337 _2doi
040			_aNLM _beng _cNLM
100	1		_aShen, De-Liang
245	0	0	_aClinical Value of CYP2C19 Genetic Testing for Guiding the Antiplatelet Therapy in a Chinese Population. _h[electronic resource]
260			_bJournal of cardiovascular pharmacology _cMar 2016
300			_a232-6 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdenosine _xadverse effects
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAsian People _xgenetics
650	0	4	_aBiotransformation
650	0	4	_aChi-Square Distribution
650	0	4	_aChina
650	0	4	_aClopidogrel
650	0	4	_aCoronary Artery Disease _xethnology
650	0	4	_aCytochrome P-450 CYP2C19 _xgenetics
650	0	4	_aDrug Monitoring _xmethods
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHemorrhage _xchemically induced
650	0	4	_aHumans
650	0	4	_aLogistic Models
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aOdds Ratio
650	0	4	_aPercutaneous Coronary Intervention _xadverse effects
650	0	4	_aPharmacogenomic Testing
650	0	4	_aPhenotype
650	0	4	_aPlatelet Aggregation Inhibitors _xadverse effects
650	0	4	_aPlatelet Function Tests
650	0	4	_aPolymorphism, Genetic
650	0	4	_aRisk Factors
650	0	4	_aTicagrelor
650	0	4	_aTiclopidine _xadverse effects
650	0	4	_aTreatment Outcome
700	1		_aWang, Bo
700	1		_aBai, Jing
700	1		_aHan, Qing
700	1		_aLiu, Chuang
700	1		_aHuang, Xiao-Hui
700	1		_aZhang, Jin-Ying
773	0		_tJournal of cardiovascular pharmacology _gvol. 67 _gno. 3 _gp. 232-6
856	4	0	_uhttps://doi.org/10.1097/FJC.0000000000000337 _zAvailable from publisher's website
999			_c25596306 _d25596306